Home Federal Bank of Tennessee lowered its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 29.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,992 shares of the company's stock after selling 6,825 shares during the quarter. Procter & Gamble makes up about 0.7% of Home Federal Bank of Tennessee's investment portfolio, making the stock its 22nd largest holding. Home Federal Bank of Tennessee's holdings in Procter & Gamble were worth $2,548,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently added to or reduced their stakes in PG. Nova Wealth Management Inc. bought a new position in Procter & Gamble during the first quarter worth $26,000. Capital A Wealth Management LLC bought a new stake in Procter & Gamble in the fourth quarter valued at $31,000. Quarry LP bought a new stake in Procter & Gamble in the first quarter valued at $33,000. Mizuho Securities Co. Ltd. lifted its stake in Procter & Gamble by 566.7% in the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after buying an additional 170 shares during the last quarter. Finally, Quest 10 Wealth Builders Inc. lifted its stake in Procter & Gamble by 50.3% in the first quarter. Quest 10 Wealth Builders Inc. now owns 245 shares of the company's stock valued at $42,000 after buying an additional 82 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on PG shares. Berenberg Bank raised their target price on Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a research note on Wednesday, September 17th. UBS Group set a $180.00 target price on Procter & Gamble and gave the company a "buy" rating in a research note on Wednesday, July 30th. Wells Fargo & Company cut their target price on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Evercore ISI restated an "in-line" rating and set a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Finally, Barclays set a $164.00 price objective on shares of Procter & Gamble and gave the company an "equal weight" rating in a research note on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $173.94.
Get Our Latest Stock Analysis on Procter & Gamble
Insider Activity
In related news, CFO Andre Schulten sold 11,638 shares of Procter & Gamble stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,830,308.26. Following the transaction, the chief financial officer owned 52,642 shares of the company's stock, valued at approximately $8,279,007.34. This trade represents a 18.11% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Marc S. Pritchard sold 9,849 shares of Procter & Gamble stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the completion of the transaction, the insider directly owned 182,422 shares in the company, valued at $28,689,507.94. This represents a 5.12% decrease in their position. The disclosure for this sale can be found here. Insiders sold 120,181 shares of company stock valued at $18,918,012 over the last quarter. Insiders own 0.20% of the company's stock.
Procter & Gamble Price Performance
NYSE:PG opened at $152.57 on Wednesday. The business's 50-day moving average price is $156.14 and its 200 day moving average price is $160.97. The firm has a market cap of $357.08 billion, a P/E ratio of 23.44, a PEG ratio of 4.04 and a beta of 0.36. Procter & Gamble Company has a 52-week low of $149.91 and a 52-week high of $180.43. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.Procter & Gamble's revenue was up 1.7% compared to the same quarter last year. During the same period in the previous year, the company earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, sell-side analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble's payout ratio is presently 64.82%.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.